• Job Description

  Req#: 67856
  Overview The Sr. Director, Development Business Operations plays a strategic and facilitative role focused on supporting the Chief Medical Officer (CMO) and the Development leadership team to deliver on their near- and long-term strategic objectives. Reporting to the CMO, the Sr. Director, Development Business Operations will have broad responsibility for strategic planning within Development, ensuring alignment with corporate objectives, and will coordinate and drive complex capability projects in partnership with senior functional leaders. S/he will manage progress against objectives and facilitate critical leadership and governance forums, including weekly staff meetings. S/he will represent the CMO in areas of day-to-day operations in partnership with functional leaders, HR and finance, and support departmental communications by planning Town Halls and other similar engagements. This individual will serve as a key member of the Development leadership team and support all areas of the organization which include: Clinical Research, Clinical Operations, Data Sciences & Statistics, Clinical Pharmacology & Pharmacometrics, Regulatory Affairs, Global Patient Safety & Risk Management and Medical Affairs. The Sr. Director, Development Business Operations will actively contribute to Development’s strategic vision, decision-making and execution as well as embody the values envisaged of company senior leaders. As the CMO’s trusted counsel, this role requires a highly resourceful person with strong emotional intelligence, self-motivation, proven collaboration abilities, and deep business acumen who thrives in a fast-paced, high intensity environment. Key Responsibilities - Act as senior level advisor and strategic sounding board to the CMO across operational, collaborative and business initiatives, activities, and deliverables – connecting the day-to-day management of the Development organization with the long-term strategic roadmap. - Lead the creation and implementation of the Development internal communications plan by supporting high-impact executive communications, including presentations for ELT and Board of Directors meetings, as well as all Company/Town Hall meetings. Support CMO in preparing, drafting, and reviewing reports, briefings, and presentations in advance of key internal and external meetings. - Develop and manage a process for measuring and reporting progress on high-priority initiatives and programs across the organization – this includes participating in key enterprise-wide efforts and leading high-profile Development initiatives . - Lead and oversee annual planning and ongoing goal and resource tracking within Development: - Drive formation and tracking of corporate and functional goals pertinent to Development. - In collaboration with Finance and Development expertise areas, coordinate investment planning process, long-range planning and oversight of actual spend; facilitate trade-off decisions. - Oversee workforce planning within Development and track to ensure focus on priority roles with appropriate trade-offs as necessary. - Develop roadmap of development capabilities in collaboration with colleagues within department and business partners. Responsible for driving progress, reporting, identifying and mitigating risks, and escalating issues related to the overall roadmap and individual projects. - Responsible for identifying, recommending, and executing a roadmap of process improvement and improved efficiency initiatives within Development. Liaise cross-functionally (Legal, Finance, Procurement, HR, and other functions as necessary) to support efficient and timely execution of Development objectives. Independently identify and resolve issues limiting execution with focus on simplification. - Manage the seamless execution of development governance model: - Oversee preparation for meetings (agendas, materials, action items). - Collaborate with meeting owners of other key governance bodies to ensure potential duplication of effort/discussion is avoided and ensure the right discussions occur at the appropriate forums. - Track interactions, identify trends and form proposals to optimize process and use of resources. - Be an active and engaged member of the Development Leadership Team. Responsible for facilitation of and participation in Development Leadership Team meetings: drive agenda setting and provide context to agenda topics, send out pre-meeting documentation, capture and share minutes to ensure that important decisions and action items are fully addressed, and assist presenters with preparation for the meetings. Qualifications - Bachelor’s degree in scientific discipline or business with 12+ years of experience in the biotechnology or pharmaceutical industry, preferably in research & development. - Excellent problem solving and execution skills with ability to multi-task. - Strong project management skills and effective matrix leader. Able to hold teams accountable to deliverables. - Ability to build strong working relationships cross-functionally and across levels. Comfortable with interacting with senior internal and external stakeholders. - Self-motivated; acts independently and prioritizes appropriately; comfortable with ambiguity; embraces unexpected changes or challenges and drives to solutions. - Solid understanding of drug development and the clinical trials process. - Strong written and oral communication skills. - Sound judgment and discretion in sensitive matters. - Ability to influence without authority. - Thrives in highly entrepreneurial biotech environment and embraces Alnylam’s culture of science, passion and urgency. - Intellectual curiosity, adaptability, and desire to learn and grow to meet the evolving needs of the organization. - Clear alignment with Alnylam Core Values - Commitment to People - Fiercely Innovative - Purposeful Sense of Urgency - Open Culture - Passion for Excellence About Alnylam Alnylam Pharmaceuticals (Nasdaq: ALNY) has led the translation of RNA interference (RNAi) into a whole new class of innovative medicines with the potential to transform the lives of people afflicted with rare and more prevalent diseases. Based on Nobel Prize-winning science, RNAi therapeutics represent a powerful, clinically validated approach to treating diseases at their genetic source by “interfering” with mRNA that cause or contribute to disease. Since our founding in 2002, Alnylam has led the RNAi Revolution and continues to turn scientific possibility into reality. Our people-first culture is guided by our core values: fiercely innovative, open culture, purposeful urgency, passion for excellence, and commitment to people, and these values influence how we work and the business decisions we make. Thanks to feedback from our employees over the years, we’ve been fortunate to be named a top employer around the world. Alnylam is extremely proud to have been recognized as the #1 Large Employer by Boston Globe Top Places to Work in 2022, one of Science Magazine’s Top Biopharma Employers, one of America's Most Responsible Companies for 2023 by Newsweek, a Fast Company Best Workplace for Innovators, and a Great Place to Work in Canada, France, Italy, Spain, Switzerland, and UK – among others. At Alnylam, we commit to an inclusive recruitment process and equal employment opportunity. We are dedicated to building an environment where employees can feel that they belong, can bring their authentic selves to work, and achieve to their full potential. By empowering employees to embrace their unique differences at work, our business grows stronger with advanced and original thinking, allowing us to bring groundbreaking medicines to patients. Qualified applicants will receive consideration for employment without regard to their race, color, religion, age, sex, sexual orientation, gender identity or expression, national origin, ethnicity, marital status, protected veteran status, disability, or any other characteristics prohibited by law. Alnylam is an E-Verify employer.

• About the company

  Alnylam Pharmaceuticals Inc. is a biopharmaceutical company focused on the discovery, development and commercialization of RNA interference therapeutics for genetically defined diseases.

Notice